Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Human biomarkers: can they help us to develop a new tuberculosis vaccine?.
FLETCHER, HA; DOCKRELL, HM;
2016
Future microbiology, (2016).11 6 10.2217/fmb.16.15.
Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
TIENTCHEU, LD; Haks, MC; AGBLA, SC; SUTHERLAND, JS; ADETIFA, IM; Donkor, S; Quinten, E; Daramy, M; ANTONIO, M; KAMPMANN, B; Ottenhoff, TH M; DOCKRELL, HM; Ota, MO;
2016
PLoS neglected tropical diseases, (2016).10 5 10.1371/journal.pntd.0004701.
Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
TIENTCHEU, L; Haks, MC; AGBLA, S; SUTHERLAND, J; ADETIFA, I; Donkor, S; Quinten, E; Daramy, M; ANTONIO, M; KAMPMANN, B; Ottenhoff, TH M; DOCKRELL, H; Ota, MO;
2016
, PLoS Neglected Tropical Diseases (2016).
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa.
Miyahara, R; JASSEH, M; Gomez, P; Shimakawa, Y; GREENWOOD, B; Keita, K; Ceesay, S; D'ALESSANDRO, U; ROCA, A;
2016
Vaccine, (2016).34 29 10.1016/j.vaccine.2016.05.017.
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.
HOWARD, N; MOUNIER-JACK, S; GALLAGHER, KE; Kabakama, S; GRIFFITHS, UK; Feletto, M; LaMontagne, DS; BURCHETT, HE D; WATSON-JONES, D;
2016
Human vaccines & immunotherapeutics, (2016).12 9 10.1080/21645515.2016.1178433.
The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage A Meta-regression Model.
DE WAROUX, OL; FLASCHE, S; PRIETO-MERINO, D;
2016
PEDIATRIC INFECTIOUS DISEASE JOURNAL, (2016).35 5 10.1097/inf.0000000000001148.
Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.
Casey, WT; SPINK, N; Cia, F; Collins, C; Romano, M; Berisio, R; BANCROFT, GJ; McClean, S;
2016
Vaccine, (2016).34 23 10.1016/j.vaccine.2016.03.088.
Yellow fever vaccine supply: a possible solution.
Monath, TP; Woodall, JP; Gubler, DJ; Yuill, TM; Mackenzie, JS; Martins, RM; Reiter, P; HEYMANN, DL;
2016
Lancet, (2016).387 10028 10.1016/S0140-6736(16)30195-7.
Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
Kieny, MP; Longini, IM; Henao-Restrepo, AM; WATSON, CH; Egger, M; EDMUNDS, WJ;
2016
Lancet, (2016).387 10027 10.1016/S0140-6736(16)00686-3.
Correction: Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
Wu, JT; JIT, M; Zheng, Y; Leung, K; Xing, W; Yang, J; Liao, Q; Cowling, BJ; Yang, B; Lau, EH Y; Takahashi, S; Farrar, JJ; Grenfell, BT; Leung, GM; Yu, H;
2016
PLoS medicine, (2016).13 4 10.1371/journal.pmed.1002013.